Wednesday, July 31 Time:11:00 - 11:20 a.m. Location: Exhibit Hall Theater #2 Sponsored by Thermo Fisher Scientific
Recent years have seen advances in automation that have brought Next-Generation Sequencing (NGS) out of specialized reference laboratories and into local pathology departments. This innovation has allowed biomarker assessment to take place “in-house”, facilitating shorter turnaround times and more efficient use of laboratory resources. During this workshop, hear how one lab with no previous NGS experience was able to adopt a rapid, amplicon based NGS profiling assay via an automated semi-conductor sequencing system. You will hear about how utilizing automated amplicon-based sequencing in-house has resulted in reduced TAT and cost savings for Doylestown Hospital.
Jeffrey Smith Thermo Fisher
Allison Eck Director of Pathology and Laboratory Medicine, Doylestown Hospital
Be the first to get all the latest news.